| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |